Bitcoin
72955.54
-1360.44
-1.86%
Crude Oil
90.07
+1.39
+1.54%
Gold
4511.4
+63
+1.4%
Copper
6.41
+0.07
+1.08%
Silver
75.19
+0.3
+0.39%
Dow Jones
50644.28
+182.59
+0.36%
SP500
7558.08
+37.72
+0.5%
NASDAQ
26674.73
+18.55
+0.07%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
28.58
+99.00%
Top Gainers
1,630,860
Top Gainers
26.9226
+74.48%
Top Gainers
2,240,106
Top Gainers
1.11
+64.86%
Top Gainers
2,296,091
Top Gainers
11.31
+61.18%
Top Gainers
1,345,642
Top Gainers
29.5803
+55.17%
Top Gainers
11,416,285
Top Gainers
966
+50.00%
Top Gainers
179,059
Top Gainers
3.78
+43.12%
Top Gainers
192,000
Top Gainers
1.7
+32.94%
Top Gainers
273,423
Top Gainers
240
+26.98%
Top Gainers
7,164,396
Top Gainers
12
+25.08%
Top Gainers
197,885
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
2280
-1620.58%
Top Loosers
476,900
Top Loosers
589
-1100.48%
Top Loosers
880,254
Top Loosers
54.09
-99.48%
Top Loosers
517,322
Top Loosers
28.59
-88.14%
Top Loosers
534,400
Top Loosers
28.36
-81.59%
Top Loosers
1,695,819
Top Loosers
82700
-81.02%
Top Loosers
763,022
Top Loosers
2.16
-50.46%
Top Loosers
25,108,332
Top Loosers
36.22
-47.74%
Top Loosers
592,801
Top Loosers
1686
-29.60%
Top Loosers
180,278
Top Loosers
5.5
-29.27%
Top Loosers
604,695
Top Loosers

In Today's Headlines

Oracle at $192: Buy, Sell or Hold?
12:06
28 May 2026
Oracle at $192: Buy, Sell or Hold?

At $192.08, Oracle (NYSE:ORCL | ORCL Price Prediction) screens favorably on backlog and valuation, with shares down sharply from last fall's peak but sitting on an AI cloud backlog few peers can match.

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
12:06
28 May 2026
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OPRX and DOCS are betting big on AI-driven healthcare engagement as cautious pharma spending pressures near-term growth.

Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions
12:06
28 May 2026
Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions

NTRA upgrades Panorama NIPT with SNP-informed deep sequencing, validated for low fetal fraction to cut no-calls and boost reliable prenatal results.

Forget The Dividend: VYM Is About Derisking From The Tech Bubble
12:04
28 May 2026
Forget The Dividend: VYM Is About Derisking From The Tech Bubble

I think VYM is a compelling tool for derisking and diversifying away from tech-heavy indices like the S&P 500. VYM's methodology selects non-hyped, shareholder-oriented large and mid-cap stocks, avoiding the 'Magnificent 7' and speculative sectors, with ~17% tech exposure. Despite its 'high yield' label, VYM's ~2.2% yield is subpar for income seekers; its strength lies in efficient, low-cost diversification and an unexpected tax efficiency in regard to dividends.

Car Sales Stink. Why GM and Ford Are Soaring.
12:03
28 May 2026
Car Sales Stink. Why GM and Ford Are Soaring.

The legacy auto makers are wading into AI with battery storage sales. That's what is driving their stocks right now—not new vehicles.

Can SHOP's 80% B2B GMV Growth Unlock a Larger Enterprise Opportunity?
12:02
28 May 2026
Can SHOP's 80% B2B GMV Growth Unlock a Larger Enterprise Opportunity?

Shopify's Q1 2026 B2B GMV surges 80% YoY as B2B tools expand to most standard plans, sharpening the case for a bigger enterprise push.

Assurant's Acquisition Strategy Fuels Growth and Expansion
12:02
28 May 2026
Assurant's Acquisition Strategy Fuels Growth and Expansion

AIZ rides on acquisitions to expand device lifecycle, automotive and connected living capabilities, strengthening growth and market reach.

The Magnificent Semis?
12:00
28 May 2026
The Magnificent Semis?

Shares of chipmakers are rallying this year While the AI spending boom is fueling big gains for lots of tech companies, it's the semiconductor makers that are truly in the chips these days.

Bronstein, Gewirtz & Grossman LLC Urges Veritone, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
12:00
28 May 2026
Bronstein, Gewirtz & Grossman LLC Urges Veritone, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Veritone (VERI) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/20/2026

Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
12:00
28 May 2026
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - May 28, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Phreesia, Inc. (NYSE: PHR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Phreesia securities between May 8, 2025 and March 30, 2026, both dates inclusive (the "Class Period").